Insider Shareholders with Direct Ownership of Edgewise Therapeutics, Inc. (EWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Edgewise Therapeutics, Inc. (EWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Edgewise Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
6,071,703 | 0 | 6,071,703 $81.3 Million | 2 |
Sep 14, 2022
Added 7.39%
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
681,812 | 0 | 681,812 $9.13 Million | 1 |
Mar 30, 2021
Added 50.0%
|
|
R Michael Carruthers
Chief Financial Officer |
296,474 | 221,327 | 86,162 $1.15 Million | 15 |
Aug 12, 2025
Reduced 1.63%
|
|
Kevin Koch
President and CEO |
58,854 | 28,239 | 30,615 $409,934 | 14 |
Aug 12, 2025
Reduced 20.66%
|
| 62,031 | 47,147 | 25,361 $339,583 | 11 |
Aug 12, 2025
Reduced 10.14%
|
|
|
Behrad Derakhshan
Chief Business Officer |
83,474 | 69,715 | 23,645 $316,606 | 18 |
Aug 12, 2025
Reduced 9.53%
|
|
Alan J Russell
Chief Scientific Officer |
378,406 | 627,736 | 23,400 $313,326 | 45 |
Aug 12, 2025
Reduced 7.54%
|
| 15,625 | 0 | 15,625 $209,218 | 1 |
Mar 30, 2021
Added 50.0%
|
|
| 12,274 | 0 | 12,274 $164,348 | 3 |
Jul 01, 2025
Added 6.53%
|
|
|
John R Moore
General Counsel |
329,788 | 324,760 | 10,214 $136,765 | 56 |
Aug 12, 2025
Reduced 17.04%
|
|
Marc Semigran
Chief Development Officer |
29,709 | 29,709 | 6,716 $89,927 | 2 |
Dec 24, 2024
Reduced 20.47%
|